Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

22d ago

PremiumCompany Announcements

Algernon Pharmaceuticals Unveils Future Plans

1M ago

PremiumPress Releases

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research’s Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

1M ago

PremiumPress Releases

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research’s Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

1M ago

PremiumCompany Announcements

Algernon Pharmaceuticals Advances DMT Stroke Study

1M ago

PremiumPress Releases

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

1M ago

More AGNPF News >

AGN News on the Web

2024-04-24

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

Yahoo Finance

Neutral

2024-04-11

Algernon Pharmaceuticals Unveils Future Plans

TipRanks News

Neutral

2024-04-11

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

Yahoo Finance

Neutral

2024-04-02

Algernon Pharmaceuticals Advances DMT Stroke Study

TipRanks News

Neutral

2024-04-01

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

Yahoo Finance

Bullish

2024-03-28

Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment

Yahoo Finance

Bullish

2024-03-27

Algernon Sells Cough Program for $2M and Equity

TipRanks News

Neutral

2024-03-27

Algernon Pharmaceuticals closes $2M acquisition of its chronic cough research program by Seyltx

Proactive Investors

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:AGN’s Media Buzz Sentiment?

Currently, no data Available

What is TSE:AGN’s weekly average amount of articles?

Currently, no data Available

What is TSE:AGN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

MTDMettler-Toledo

ALCAlcon

CABACabaletta Bio

PYXSPyxis Oncology

BOLTBolt Biotherapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing